National Health Investors Inc NHI
Institutional shares held
26 Million
43.9K
calls
6K
puts
Total value of holdings
$1.74B
$2.93M
calls
$400K
puts
Market Cap
$2.98B
44,655,200
Shares Out.
Institutional ownership
58.26%
# of Institutions
230
We take great care to ensure that the data presented and summarized in this overview for NATIONAL HEALTH INVESTORS INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding NHI
View all-
Vanguard Group Inc Valley Forge, PA6.19MShares$413 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.31MShares$288 Million0.01% of portfolio
-
State Street Corp Boston, MA1.88MShares$125 Million0.01% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.79MShares$120 Million0.07% of portfolio
-
Macquarie Group LTD Australia, C31.12MShares$74.8 Million0.08% of portfolio
-
Geode Capital Management, LLC Boston, MA1.04MShares$69.4 Million0.01% of portfolio
-
Bank Of America Corp Charlotte, NC809KShares$54 Million0.0% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA716KShares$47.8 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX611KShares$40.8 Million0.01% of portfolio
-
Northern Trust Corp Chicago, IL525KShares$35 Million0.01% of portfolio
Latest Institutional Activity in NHI
Top Purchases
Top Sells
About NHI
Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
Insider Transactions at NHI
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 31
2024
|
Robert A Mccabe Jr Director |
BUY
Open market or private purchase
|
Direct |
437
+1.98%
|
$28,405
$65.83 P/Share
|
|
May 06
2024
|
John L Spaid CFO/EVP Finance |
SELL
Payment of exercise price or tax liability
|
Direct |
230
-1.26%
|
$14,720
$64.72 P/Share
|
|
Feb 27
2024
|
Charlotte A Swafford Director |
BUY
Open market or private purchase
|
Indirect |
10,000
+8.32%
|
$580,000
$58.69 P/Share
|
|
Feb 23
2024
|
David L Travis SVP/Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+30.0%
|
-
|
|
Feb 23
2024
|
John L Spaid CFO/EVP Finance |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+14.1%
|
-
|
|
Feb 23
2024
|
Kevin Carlton Pascoe Chief Investment Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+6.99%
|
-
|
|
Feb 23
2024
|
Kristin Sallee Gaines SVP/Chief Transaction Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+5.49%
|
-
|
|
Feb 23
2024
|
D. Eric Mendelsohn CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+5.24%
|
-
|
|
Oct 01
2023
|
Robert G Adams Director |
SELL
Acquisition or disposition by will or laws
|
Indirect |
85,411
-100.0%
|
-
|
|
Aug 30
2023
|
James R Jobe Director |
BUY
Open market or private purchase
|
Direct |
1,000
+6.26%
|
$51,000
$51.4 P/Share
|
|
May 05
2023
|
Kevin Carlton Pascoe Chief Investment Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,000
+9.78%
|
-
|
|
May 05
2023
|
John L Spaid CFO/EVP Finance |
BUY
Grant, award, or other acquisition
|
Direct |
4,000
+20.75%
|
-
|
|
May 05
2023
|
Kristin Sallee Gaines SVP/Chief Transaction Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,000
+7.6%
|
-
|
|
May 05
2023
|
D. Eric Mendelsohn CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+8.89%
|
-
|
|
May 05
2023
|
David L Travis SVP/Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,000
+50.0%
|
-
|
|
Dec 14
2022
|
Robert G Adams Director |
BUY
Open market or private purchase
|
Indirect |
1,000
+0.55%
|
$56,000
$56.6 P/Share
|
|
Aug 26
2022
|
Kevin Carlton Pascoe Chief Investment Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
16,065
-32.81%
|
$1,076,355
$67.1 P/Share
|
|
Aug 26
2022
|
Kevin Carlton Pascoe Chief Investment Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,333
+27.24%
|
$971,649
$53.41 P/Share
|
|
Aug 15
2022
|
Robert G Adams Director |
BUY
Open market or private purchase
|
Indirect |
1,500
+1.73%
|
$97,500
$65.93 P/Share
|
|
Dec 30
2021
|
Robert G Adams Director |
BUY
Open market or private purchase
|
Indirect |
2,000
+1.16%
|
$114,000
$57.25 P/Share
|
Last 12 Months Summary
Buy / Acquisition
26.4K
Shares
From
8
Insiders
| Grant, award, or other acquisition | 15K shares |
|---|---|
| Open market or private purchase | 11.4K shares |
Sell / Disposition
85.6K
Shares
From
2
Insiders
| Acquisition or disposition by will or laws | 85.4K shares |
|---|---|
| Payment of exercise price or tax liability | 230 shares |